The American Statistical Association is grateful to all the Associate Editors who made the 2023 volume year of Statistics in Biopharmaceutical Research a success
Ionut Bebu, The George Washington University
Björn Bornkamp, Novartis Pharma AG
Aloka Chakravarty, FDA
Ivan Chan, AbbVie Inc
Jonathan Chipman, University of Utah Health
Freda Cooner, Amgen Inc
Guoqing Diao, The George Washington University Milken Institute of Public Health
Vladimir Dragalin, JNJ Ltd
Yixin Fang, AbbVie Inc
Dean Follmann, National Institute of Allergy and Infectious Diseases
Weili Hi, AbbVie Inc.
Lisa Hampson, Novartis AG
Weili He, AbbVie Inc
Antje Hoering, Cancer Research And Biostatistics
Chinfu Hsiao, National Health Research Institutes
Bo Huang, Pfizer
Kelly Van Lancker, Ghent University
Hope Knuckles, Abbott Laboratories
Chia-Wen Ko, Food and Drug Administration
Lu Mao, University of Wisconsin-Madison
David Ohlssen, Novartis Pharmaceuticals Corporation
Gene Pennello, Food and Drug Administration
Inna Perevozskaya, Glaxo SmithKline Research and Development Research Triangle Park
William Rosenberger, George Mason University
Estelle Russek-Cohen, ERCStatLLC
Brian Smith, Amgen
Oleksandr Sverdlov, Novartis Pharmaceutical Corporation
Kentaro Takeda, Astellas Pharma Global Development, Inc
Dejun Tang, Novartis
Lu Tian, Stanford University
Xiaofei Wang, Duke University
Jiawei Wei, Novartis AG
Dong Xi, Gilead Sciences Inc
Dandan Xu, US Food and Drug Administration
Ting Ye, Wharton School, Univ. of Pennsylvania
Binbing Yu, AstraZeneca US
Sarah Zohar, INSERM